← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2016Last known activity
Aug 1, 2016
Defunct as of Apr 1, 2018
Timeline
2010s
- Oct 1, 2012
Heart Metabolics— Founded
- Apr 1, 2018
Heart Metabolics— Defunct
Drugs by trial phase (1 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT02862600Study chairPhase 2Aug 1, 2016
- NCT02862600Lead sponsorPhase 2Aug 1, 2016
- NCT02431221Lead sponsorPhase 3Mar 1, 2016
Details
- Founded
- San Francisco, CA, US Oct 1, 2012
- Last known activity
- Aug 1, 2016